Fluorescently Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study
Anthony B. Morlandt, Lindsay S. Moore, Aubrey O. Johnson, Caris M. Smith, Todd M. Stevens, Jason M. Warram, Mary MacDougall, Eben L. Rosenthal, Hope M. Amm
Topics & Concepts
MedicineAmeloblastomaCetuximabProof of conceptSurgical excisionSurgeryDentistryCancerInternal medicineMaxillaColorectal cancerOperating systemComputer scienceOral and Maxillofacial PathologyCancer Research and TreatmentsBone and Dental Protein Studies